Literature DB >> 10573471

Medication cost reduction in children on the ketogenic diet: data from a prospective study.

D L Gilbert1, P L Pyzik, E P Vining, J M Freeman.   

Abstract

In a prospective study of the efficacy of the ketogenic diet in children with severe, refractory epilepsy, data were collected on medication changes over 1 year. Cost reductions in medications were calculated over the first year and estimated for a second year. Fifty-seven percent of the children stayed on the diet for 1 year, and 74% of these children had their number of medications reduced. Forty-eight percent of children who stayed on the diet were on no medications at 12 months follow-up. Daily medication costs were reduced by nearly 70%.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573471     DOI: 10.1177/088307389901400712

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

1.  The ketogenic diet, four score and seven years later.

Authors:  Douglas R Nordli
Journal:  Nat Clin Pract Neurol       Date:  2009-01

Review 2.  Is complementary and alternative medicine (CAM) cost-effective? A systematic review.

Authors:  Patricia M Herman; Benjamin M Craig; Opher Caspi
Journal:  BMC Complement Altern Med       Date:  2005-06-02       Impact factor: 3.659

3.  The CORE-KDT study: a mixed methods protocol to establish core outcomes for refractory childhood epilepsy treated with ketogenic diet therapy.

Authors:  Jennifer H Carroll; J Helen Cross; Mary Hickson; Emma Williams; Valerie Aldridge; Avril Collinson
Journal:  Trials       Date:  2022-08-17       Impact factor: 2.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.